Literature DB >> 8696295

Central enhancement of taste pleasure by intraventricular morphine.

S Peciña1, K C Berridge.   

Abstract

Do centrally-administered opioid agonists stimulate feeding by enhancing the palatability of foods? This hypothesis has been supported by several lines of evidence, including previous 'taste reactivity' studies of the influence of systemic morphine on affective (hedonic and aversive) behavioral reactions to taste palatability. The presents study examined whether opioid agonists enhance palatability by acting centrally on brain palatability systems. Here we report the effect of intraventricular microinjections of morphine (0, 12, 25, 50 nmols) on hedonic taste reactions to a 0.12 M sucrose solution. The effect on feeding was also assessed in order to determine whether feeding and palatability enhancement are linked, as would be required by the hypothesis that feeding is due to enhanced palatability. Both hedonic taste reactivity patterns and feeding were significantly increased together by morphine administration into the lateral ventricle. We conclude that opioid-induced enhancement of the hedonic palatability of food is a centrally mediated effect. Enhancement of food palatability may be an important psychological route by which intracranial administration of opioid agonists induce feeding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8696295

Source DB:  PubMed          Journal:  Neurobiology (Bp)        ISSN: 1216-8068


  14 in total

1.  Extended heroin access increases heroin choices over a potent nondrug alternative.

Authors:  Magalie Lenoir; Lauriane Cantin; Nathalie Vanhille; Fuschia Serre; Serge H Ahmed
Journal:  Neuropsychopharmacology       Date:  2013-01-15       Impact factor: 7.853

2.  Intra-accumbens infusion of a muscarinic antagonist reduces food intake without altering the incentive properties of food-associated cues.

Authors:  Michelle L Perry; Matthew E Andrzejewski; Susan M Bushek; Brian A Baldo
Journal:  Behav Neurosci       Date:  2010-02       Impact factor: 1.912

3.  The role of dose and restriction state on morphine-, cocaine-, and LiCl-induced suppression of saccharin intake: A comprehensive analysis.

Authors:  Robert C Twining; Christopher S Freet; Robert A Wheeler; Christian G Reich; Dennie A Tompers; Sarah E Wolpert; Patricia S Grigson
Journal:  Physiol Behav       Date:  2016-04-13

4.  Sucrose-enriched diet during maturation increases ethanol preference in rats.

Authors:  M V Dorofeikova; A Yu Egorov; E V Filatova; A A Orlov
Journal:  Dokl Biol Sci       Date:  2017-09-01

5.  High on food: the interaction between the neural circuits for feeding and for reward.

Authors:  Jing-Jing Liu; Diptendu Mukherjee; Doron Haritan; Bogna Ignatowska-Jankowska; Ji Liu; Ami Citri; Zhiping P Pang
Journal:  Front Biol (Beijing)       Date:  2015-02-10

6.  Increases in food intake or food-seeking behavior induced by GABAergic, opioid, or dopaminergic stimulation of the nucleus accumbens: is it hunger?

Authors:  Erin C Hanlon; Brian A Baldo; Ken Sadeghian; Ann E Kelley
Journal:  Psychopharmacology (Berl)       Date:  2003-11-04       Impact factor: 4.530

Review 7.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

Review 8.  Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake.

Authors:  Nicole M Avena; Pedro Rada; Bartley G Hoebel
Journal:  Neurosci Biobehav Rev       Date:  2007-05-18       Impact factor: 8.989

Review 9.  Mapping brain circuits of reward and motivation: in the footsteps of Ann Kelley.

Authors:  Jocelyn M Richard; Daniel C Castro; Alexandra G Difeliceantonio; Mike J F Robinson; Kent C Berridge
Journal:  Neurosci Biobehav Rev       Date:  2012-12-19       Impact factor: 8.989

10.  Modulation of feeding and locomotion through mu and delta opioid receptor signaling in the nucleus accumbens.

Authors:  Yoshihiro Katsuura; Sharif A Taha
Journal:  Neuropeptides       Date:  2009-12-30       Impact factor: 3.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.